Market Research Report
Rabies Diagnostics Market Size, Share & Trends Analysis Report By Diagnostic Methods (Fluorescent Antibody Test, Histologic, Serology), By Technology (ELISA, PCR), And Segment Forecasts, 2019 - 2025
|Published by||Grand View Research, Inc.||Product code||793765|
|Published||Content info||110 Pages
Delivery time: 2-3 business days
|Rabies Diagnostics Market Size, Share & Trends Analysis Report By Diagnostic Methods (Fluorescent Antibody Test, Histologic, Serology), By Technology (ELISA, PCR), And Segment Forecasts, 2019 - 2025|
|Published: February 6, 2019||Content info: 110 Pages||
The global rabies diagnostics market size is expected to reach USD 2.03 billion by 2025 and is projected to expand at a CAGR of 4.1% during the forecast period, according to a new report by Grand View Research, Inc. Development of various diagnostic assays ranging from detection of virus presence to final confirmation of infection helps launch effective disease control programs. This factor is anticipated to drive the market growth. These assays aid in defining epidemiologic patterns of the disease and thereby deliver appropriate information for designing the control and eradication programs. These programs have boosted the market growth by increasing the rate at which testing kits are adopted.
For example, in June 2018, the World Health Organization (WHO), the World Organization for Animal Health (OIE), the Global Alliance for Rabies Control (GARC), and the Food and Agriculture Organization of the United Nations (FAO) entered into a partnership for a plan, The United Against Rabies Collaboration. This plan aims for rabies prevention and management and empowering the under-served populations in afflicted countries.
Furthermore, the state and public health officials of the Department of Public Health and Human Services (DPHHS) along with the Department of Livestock of Montana, U.S., deal with awareness pertaining to the risk of virus exposure. They are engaged in training the population about various aspects of disease management including prevention, detection, and available treatment modes. Such initiatives are projected to create growth opportunities for the rabies diagnostics market during the forecast period.
Bio-Rad Laboratories, Inc.; Merck KGaA; Aviva Systems Biology Corporation; and Creative Diagnostics are some of the key entities in the rabies testing market. The companies engage in developing products for rabies eradication programs.